Bone marrow status on day 7 and day 14
| BM status . | Pegaspargase . | Native ASNase . | ||
|---|---|---|---|---|
| Day 7 . | Day 14 . | Day 7 . | Day 14 . | |
| M1 | 36 (63) | 524-150 (96) | 26 (47) | 434-151 (83) |
| M2 | 13 (23) | 2 (4) | 13 (24) | 5 (10) |
| M3 | 8 (14) | 0 | 16 (29) | 4 (8) |
| Total patients | 57 (100) | 54 (100) | 55 (100) | 52 (100) |
| BM status . | Pegaspargase . | Native ASNase . | ||
|---|---|---|---|---|
| Day 7 . | Day 14 . | Day 7 . | Day 14 . | |
| M1 | 36 (63) | 524-150 (96) | 26 (47) | 434-151 (83) |
| M2 | 13 (23) | 2 (4) | 13 (24) | 5 (10) |
| M3 | 8 (14) | 0 | 16 (29) | 4 (8) |
| Total patients | 57 (100) | 54 (100) | 55 (100) | 52 (100) |
Entries are numbers of patients; parentheticals are percentages. Two patients were excluded from analysis: one had Philadelphia chromosome and one received both asparaginase preparations.
BM indicates bone marrow.
This number includes 34 patients with M1 bone marrow on day 7 and day 28 who did not have a bone marrow aspirate on day 14.
This number includes 24 patients with M1 bone marrow on day 7 and day 28 who did not have a bone marrow aspirate on day 14.